These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 13697901)

  • 1. Evaluation of trisodium calcium diethylenetriaminepentacetate in iron storage disease.
    FAHEY JL; RATH CE; PRINCIOTTO JV; BRICK IB; RUBIN M
    J Lab Clin Med; 1961 Mar; 57():436-49. PubMed ID: 13697901
    [No Abstract]   [Full Text] [Related]  

  • 2. [Metabolism of iron and copper, action of chelators and therapeutic possibilities in Wilson's disease and hemochromatosis].
    PIRART J
    Pathol Biol; 1961 May; 9():1157-74. PubMed ID: 13735975
    [No Abstract]   [Full Text] [Related]  

  • 3. EFFECT OF TRISODIUM CALCIUM DIETHYLENETRIAMINEPENTAACETATE ON BIVALENT CATIONS IN THALASSEMIA MAJOR.
    MULLER-EBERHARD U; ERLANDSON ME; GINN HE; SMITH CH
    Blood; 1963 Aug; 22():209-17. PubMed ID: 14045304
    [No Abstract]   [Full Text] [Related]  

  • 4. [THE EFFECT OF PHOSPHORUS AND CALCIUM SALTS AND IRON-POOR DIET OR IRON-FREE NUTRITION ON THE IRON EXCRETION BALANCE OF PATIENTS WITH HEMOCHROMATOSIS RECEIVING DESFERRIOXAMINE THERAPY].
    TEUBNER K; WEISE HJ
    Verh Dtsch Ges Inn Med; 1964; 70():404-6. PubMed ID: 14294251
    [No Abstract]   [Full Text] [Related]  

  • 5. [The use of chelating substances for the recognition of states of iron overloading].
    CAPRIO G
    Osp Maggiore; 1961 Jul; 49():277-9. PubMed ID: 13876386
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of hemochromatosis].
    WOEHLER F
    Med Klin; 1962 Aug; 57():1370-6. PubMed ID: 14007830
    [No Abstract]   [Full Text] [Related]  

  • 7. Hereditary hemochromatosis.
    Walker EM; Wolfe MD; Norton ML; Walker SM; Jones MM
    Ann Clin Lab Sci; 1998; 28(5):300-12. PubMed ID: 9784832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Idiopathic hemochromatosis, an iron storage disease. A. Iron metabolism in hemochromatosis.
    FINCH SC; FINCH CA
    Medicine (Baltimore); 1955 Dec; 34(4):381-430. PubMed ID: 13272508
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of chelating agents on utilization of calcium, iron and manganese by the chick.
    Fritz JC; Pla GW; Boehne JW
    Poult Sci; 1971 Sep; 50(5):1444-50. PubMed ID: 4999314
    [No Abstract]   [Full Text] [Related]  

  • 10. Iron metabolism and chelation therapy in hemosiderosis.
    Graziano JH
    Curr Top Hematol; 1978; 1():127-50. PubMed ID: 400529
    [No Abstract]   [Full Text] [Related]  

  • 11. [Iron metabolism].
    Maspes VE; Barretto OC; Tamigaki M
    Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):282-9. PubMed ID: 3455558
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapeutic efficacy in hypochromic anemia of a preparation with iron chelate base. Our clinical experience on 50 cases].
    DAL MONTE PR
    Gazz Med Ital; 1960 Nov; 119():470-5. PubMed ID: 13719388
    [No Abstract]   [Full Text] [Related]  

  • 13. Iron chelation therapy in hereditary hemochromatosis and thalassemia intermedia: regulatory and non regulatory mechanisms of increased iron absorption.
    Kontoghiorghes GJ; Spyrou A; Kolnagou A
    Hemoglobin; 2010 Jun; 34(3):251-64. PubMed ID: 20524815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hemochromatosis].
    Simon M; Hespel JP; Brissot P; Fauchet R; Edan G; Le Reun M; Le Mignon L; Genetet B; Bourel M
    Ann Med Interne (Paris); 1981; 132(6):413-33. PubMed ID: 7032384
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiopathology of iron metabolism and hemochromatosis: interrelationships, assessment and pathogenesis of iron overload, screening].
    Carrella M; Del Piano C
    Ann Ital Med Int; 1989; 4(4):396-407. PubMed ID: 2487794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of urinary elimination of iron by a chelate (edathamil calcium) in hemochromatosis].
    AVRIL J; DREUX C; KLOTZ HP; PARIENTE R
    Bull Mem Soc Med Hop Paris; 1956 Oct; 72(24-25):724-7. PubMed ID: 13374539
    [No Abstract]   [Full Text] [Related]  

  • 17. [Hemochromatosis: one form of iron-overload diseases].
    Szalay F
    Orv Hetil; 2013 Jul; 154(29):1156-64. PubMed ID: 23853349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy.
    McLaren GD; Muir WA; Kellermeyer RW
    Crit Rev Clin Lab Sci; 1983; 19(3):205-66. PubMed ID: 6373141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hemochromatosis and iron chelating therapy].
    Hershko C; Link AG; Pinson A; Grisaru S; Sarel S; Grady RW
    Harefuah; 1986 Nov; 111(10):336-8. PubMed ID: 3546013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiopathology, diagnosis and therapy of hemochromatosis].
    Palmas S
    Clin Ter; 1980 Jan; 92(1):63-88. PubMed ID: 7004748
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.